Abstract
Ettore Lo Cascio, Angelo Toto, Gabriele Babini, Alvaro Mordente, Stefano Della Longa, Alessandro Arcovito
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local citing links have been materialized yet.
10.1056/nejmoa2001017
10.1056/nejmoa2001017
10.1111/bph.15143
10.1111/bph.15143
10.1038/s41467-020-19619-7
10.1038/s41467-020-19619-7
10.1016/j.meegid.2020.104384
10.1016/j.meegid.2020.104384
Genetic diversity and evolution of SARS-CoV-2
10.1016/j.meegid.2020.104260 · 2020
Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus nonstructural proteins identifies unique and shared host-cell dependencies
2020
10.1016/s1473-3099(20)30484-9
10.1016/s1473-3099(20)30484-9
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
10.1186/s12931-020-01479-w · 2020
10.1038/s41586-020-2179-y
10.1038/s41586-020-2179-y
Structural and functional basis of SARS-CoV-2 entry by using human ACE2
10.1016/j.cell.2020.03.045 · 2020
10.1021/acs.jpclett.0c01064
10.1021/acs.jpclett.0c01064
10.1021/acs.jpclett.0c01148
10.1021/acs.jpclett.0c01148
Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein
10.1016/j.cell.2020.02.058 · 2020
10.1073/pnas.2008209117
10.1073/pnas.2008209117
10.1126/science.abb2762
10.1126/science.abb2762
10.1016/j.csbj.2020.09.019
10.1016/j.csbj.2020.09.019
10.1021/acsnano.0c04674
10.1021/acsnano.0c04674
10.20944/preprints202004.0439.v1
10.20944/preprints202004.0439.v1
10.1128/msystems.00382-20
10.1128/msystems.00382-20
Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
2020
10.1038/s41467-020-18709-w
10.1038/s41467-020-18709-w
10.1016/j.jpha.2020.04.008
10.1016/j.jpha.2020.04.008
Molecular insights into small molecule drug discovery for SARS-CoV-2
2020
Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
2021
10.31219/osf.io/rkz9n
10.31219/osf.io/rkz9n
Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
10.1073/pnas.2021946118 · 2021
RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic
10.1016/j.ejmech.2021.113201 · 2021
10.1074/jbc.ra120.014873
10.1074/jbc.ra120.014873
Host-membrane interacting interface of the SARS coronavirus envelope protein: immense functional potential of C-terminal domain
10.1016/j.bpc.2020.106452 · 2020
10.1091/mbc.e10-04-0338
10.1091/mbc.e10-04-0338
Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis
10.1128/mbio.02325-17 · 2018
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis
2020
Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein
10.1002/pro.3936 · 2020
Prediction of virus-host protein-protein interactions mediated by short linear motifs
10.1186/s12859-017-1570-7 · 2017
10.1107/s139900471402776x
10.1107/s139900471402776x
10.1073/pnas.1416515111
10.1073/pnas.1416515111
10.1021/ct100578z
10.1021/ct100578z
10.1016/s0022-2836(02)00470-9
10.1016/s0022-2836(02)00470-9
10.1016/j.softx.2015.06.001
10.1016/j.softx.2015.06.001
10.1038/nmeth.4067
10.1038/nmeth.4067
10.1002/jcc.20084
10.1002/jcc.20084 · doi-reference
10.1021/acs.jctc.8b00839
10.1021/acs.jctc.8b00839 · doi-reference
10.1002/jcc.20281
10.1002/jcc.20281 · doi-reference
10.1021/acs.macromol.5b02148
10.1021/acs.macromol.5b02148 · doi-reference
10.1002/jcc.21787
10.1002/jcc.21787 · doi-reference
10.1021/acs.jctc.5b00935
10.1021/acs.jctc.5b00935 · doi-reference